36 results on '"Higgs, Braden"'
Search Results
2. Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection
3. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
4. Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II
5. Dose-effect Relationship of Kidney Function After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: Trog 15.03 Fastrack Ii
6. Patient-reported functional outcome measures and treatment choice for prostate cancer
7. Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card
8. Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer
9. Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer.
10. Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method
11. Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
12. To leave, or not to leave? Management of a thyroglossal duct cyst carcinoma
13. Patterns of practice regarding use of radiation therapy following radical prostatectomy: A survey of Radiation Oncologists and Urologists in Australia and New Zealand.
14. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
15. Additional file 1 of Patient-reported functional outcome measures and treatment choice for prostate cancer
16. Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand
17. Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study
18. Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
19. Ophthalmic and adnexal complications of radiotherapy
20. Sa1650 – Endorectal Balloon (ERB) During Image Guided Radiation Therapy (IGRT) for Carcinoma of the Prostate (CAP) Reduces Long Term Radiation Induced Rectal Bleeding and Subsequent Argon Plasma Coagulation (APC) Treatment
21. Malignant mesothelioma of the tunica vaginalis: a atypical presentation of a rare scrotal tumour
22. Su1603 - Endorectal Balloon (ERB) Reduces Radiation-Induced Rectal Bleeding One Year Post-Treatment of Carcinoma of Prostate (CAP) with Image Guided Radiation Therapy (IGRT)
23. Endorectal Balloon (ERB) During Image Guided Radiation Therapy (IGRT) for Carcinoma of the Prostate (CAP) Reduces Long Term Radiation-Induced Rectal Bleeding and Sensory Dysfunction and Improves Global Health Related Quality of Life (HRQOL)
24. Tu1762 Endorectal Balloon (ERB) During Image Guided Radiation Therapy (IGRT) for Carcinoma of the Prostate (CAP) Reduces Rectal Bleeding and Anorectal Sensory Dysfunction and Improves Health Related Quality of Life (HRQOL) Outcomes at 2 Years
25. A Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy (3DCRT) with Helical Intensity Modulated Radiotherapy (Tomotherapy) for Oropharyngeal Carcinoma
26. Sa1342 Endorectal Balloon (ERB) During Image Guided Radiation Therapy (IGRT) for Carcinoma of the Prostate (CAP) Reduces Gastrointestinal (GI) Dysfunction and Improves Health Related Quality of Life (HRQoL) Scores at 1 Year
27. Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: A retrospective study
28. Sa1628 - Endorectal Balloon (ERB) During Image Guided Radiation Therapy (IGRT) for Carcinoma of the Prostate (CAP) Reduces Long Term Radiation-Induced Rectal Bleeding and Sensory Dysfunction and Improves Global Health Related Quality of Life (HRQOL)
29. Multiple cranial nerve palsies as a result of perineural invasion by squamous cell carcinoma
30. Ophthalmic and adnexal complications of radiotherapy
31. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
32. Multiple cranial nerve palsies as a result of perineural invasion by squamous cell carcinoma.
33. Patient-reported functional outcome measures at baseline and 12 months of commencing prostate cancer treatment
34. Patient-reported functional outcome measures and treatment choice for prostate cancer
35. Evaluation of hypofractionated radiation therapy use and patient-reported outcomes in men with nonmetastatic prostate cancer in Australia and New Zealand
36. Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.